Hydroxyurea in thalassemia intermedia-a promising therapy

Nika · #1 (**permalink**) 04-20-2005, 08:08 PM

Source:
Ann Hematol. 2005 Apr 19; [Epub ahead of print]

Hydroxyurea in thalassemia intermedia-a promising therapy.

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Department of Haematology, All India Institute of Medical Sciences, New Delhi, India, vedpchoudhry@yahoo.co.in.

Pharmacological agents such as hydroxyurea (HU) have been known to cause induction of fetal hemoglobin and possibly may alleviate the symptoms in thalassemia intermedia patients. Thirty-seven patients with beta-thalassemia intermedia were enrolled to assess response to HU therapy. Major response was defined as transfusion independence or hemoglobin rise of more than 20 g/l and minor response as rise in hemoglobin of 10-20 g/l or reduction in transfusion frequency by 50%. The median age was 10 years (range: 4-50 years) and median follow-up was 12 months (range: 4-36 months). Twenty-six patients (70.2%) showed response to HU therapy. Seventeen patients (45.9%) were major responders, and nine patients (24.3%) showed minor response. There was no correlation of response with beta-thalassemia mutation or XmnI polymorphism; however, the presence of alpha(3.7) deletion was associated with major response in three patients. Mean fetal hemoglobin (HbF) levels rose on HU therapy. Older age, low baseline F cell percent, and low baseline HbF levels (below 10%) were predictors of poor response. Response was evident within 1 month of starting HU therapy in the majority of responders. Thus, a short trial of HU therapy can predict durable response.

PMID: 15838670 [PubMed - as supplied by publisher]

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search
Display Modes	Rate This Thread
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode	Rate This Thread:

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia	Nika	Medical Articles and Abstracts	0	03-16-2005 10:34 PM
Long-term Use of Hydroxyurea for Sickle Cell Anemia	Ulf Scheithauer	Medical Articles and Abstracts	0	02-04-2005 04:08 AM
Work on promising inorganic blood substitute to move forward with $1.5 million grant	Jan B. Wade	News and Hot Topics such as Hepatitis C, SARS and AIDS	0	04-21-2004 06:28 AM
blood salvage during cesarean delivery in a patient with beta thalassemia intermedia	Jan B. Wade	Medical Articles and Abstracts	0	02-06-2004 09:59 AM
Long-term Use of Hydroxyurea for Sickle Cell Anemia	jmarti49	Medical Articles and Abstracts	0	08-14-2003 10:36 AM

Hydroxyurea in thalassemia intermedia-a promising therapy

Welcome to the latest in bloodless medicine and blood transfusion alternatives.

We are a community of medical professionals and members of the public who are responding to the worldwide concern about the efficacy, cost and availability of donor blood.

Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)